Chemoinformaics analysis of (R)-4-Isopropylcyclohex-2-enone
| Molecular Weight | 138.21 | nRot | 1 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 7 |
| Exact Molecular Weight | 138.104 | nRing | 1 |
| Solubility: LogS | -1.571 | nHRing | 0 |
| Solubility: LogP | 2.012 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.1671 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.508 |
| Synth | 3.09 |
| Natural Product Likeliness | 2.279 |
| NR-PPAR-gamma | 0.085 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.04 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.361 |
| MDCK | 0.000026 |
| BBB | 0.996 |
| PPB | 0.62807 |
| VDSS | 0.942 |
| FU | 0.284553 |
| CYP1A2-inh | 0.366 |
| CYP1A2-sub | 0.527 |
| CYP2c19-inh | 0.087 |
| CYP2c19-sub | 0.702 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.789 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.258 |
| CL | 8.293 |
| T12 | 0.869 |
| hERG | 0.005 |
| Ames | 0.236 |
| ROA | 0.037 |
| SkinSen | 0.103 |
| Carcinogencity | 0.946 |
| EI | 0.889 |
| Respiratory | 0.794 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.950797 |